whoa. whoa. whoa.

You're being directed to the ELOCTATE Healthcare Professional website. If you're okay with that, we're okay with that.

Come back soon!

Home Hero

Craig tells his own story

Craig is a writer and performer who refuses to let Hemophilia A speak for him.

When his doctor told him ELOCTATE prophylaxis offers bleed protection* you can count on, he started a new chapter in his treatment journey.

*ELOCTATE has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.


You are a self-described passionate man. What are your passions?

I'm passionate about fairness and equality. I grew up with Hemophilia A feeling like I was treated differently, like I was sometimes judged. I'm also passionate about my creativity and restoring old cars.

How did you feel when your doctor suggested ELOCTATE?

I approached my switch to ELOCTATE the same way I approach life—with a sense of possibility.

What do you like about ELOCTATE?

I feel ELOCTATE offers me the bleed and joint bleed protection I need to explore the passions I have — protection I can count on.

And what's in store for your next chapter?

I like to talk to other people about Hemophilia A, at conferences, one-on-one, and I'm constantly moved by the way my stories affect other people, the way they touch other people.

Note: Patient stories reflect the real-life experiences of persons diagnosed with hemophilia A who have been prescribed ELOCTATE. However, individual experiences may vary. Patient stories are not necessarily representative of what another person using ELOCTATE may experience. Talk to your healthcare provider about what's right for you. ELOCTATE Peers have been compensated for sharing their stories.

The recommended starting regimen is 50 IU/kg every 4 days as directed by your doctor. In children under 6 years of age, the recommended starting regimen is 50 IU/kg administered twice weekly. The regimen can be adjusted based on your body's individual response.




Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.

Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort.

If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk.

These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE.


ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.



Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078